2BB score and signals
Protara Therapeutics, Inc.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 56 | Moderate |
| Momentum | 49 | Stable |
| Financial strength | 23 | Weak |
| Quality | 60 | Normal |
| Risk | 53 | Moderate |
Protara Therapeutics, Inc. (TARA) Stock Score & Signals
Protara Therapeutics, Inc. (TARA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 42 out of 100.
Company facts
| Founded | 2006 |
| Employees | 46 |
| 52-week range | $2.47 – $7.82 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-08 | — | -0.3745 | — | $0.00 |
| 2026-10-29 | — | -0.373 | — | $0.00 |
| 2026-07-30 | — | -0.3322 | — | $0.00 |
| 2026-05-13 | -0.31 | -0.3818 | $0.00 | $0.00 |